Showing 21 - 40 results of 168 for search '"Eye disease"', query time: 0.06s Refine Results
  1. 21

    Retinal Surface Macrophage Changes in Thyroid Eye Disease before and after Treatment with Teprotumumab by Oscar Otero-Marquez, Mona Fayad, Alexander Pinhas, Toco Y. P. Chui, Richard B. Rosen, Harsha S. Reddy

    Published 2022-01-01
    “…We examined the variation of parafoveal surface macrophages in a thyroid eye disease (TED) patient before and after treatment with teprotumumab (Tepezza, Horizon therapeutics). …”
    Get full text
    Article
  2. 22
  3. 23
  4. 24

    Oral Hyaluronic Acid Supplementation for the Treatment of Dry Eye Disease: A Pilot Study by Yeseul Kim, Chan Hee Moon, Bo-Yeon Kim, Sun Young Jang

    Published 2019-01-01
    “…To evaluate the clinical efficacy of oral hyaluronic acid (HA) in patients with dry eye disease (DED). Study Design. Prospective randomized controlled trial. …”
    Get full text
    Article
  5. 25

    Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease by Kyung In Woo, Suk-Woo Yang, Jeong Kyu Lee, Sang In Khwarg, Jin Sook Yoon, Sehyun Baek, Jae Wook Yang, JaeSang Ko, Koung Hoon Kook, Sang Duck Kim, Jun Hyuk Son, Helen Lew, Sung Bok Lee, Jae Woo Jang, Hee Young Choi, Mi Jung Chi

    Published 2022-06-01
    “…Objectives The clinical course of thyroid eye disease (TED) is heterogeneous and predicting patients who may develop the severe sequelae of the disease is difficult. …”
    Get full text
    Article
  6. 26

    Mesenchymal Stem Cell–Sourced Exosomes as Potentially Novel Remedies for Severe Dry Eye Disease by Carl Randall Harrell, Valentin Djonov, Ana Volarevic, Aleksandar Arsenijevic, Vladislav Volarevic

    Published 2025-01-01
    “…Severe dry eye disease (DED) is an inflammatory condition characterized by a lack of sufficient moisture or lubrication on the surface of the eye, significantly impacting the quality of life and visual function. …”
    Get full text
    Article
  7. 27
  8. 28

    TOM500: A Multi-Organ Annotated Orbital MRI Dataset for Thyroid Eye Disease by Haiyang Zhang, Hoi Chi Chan, Jiashuo Xu, Mengda Jiang, Xiaofeng Tao, Huifang Zhou, Xuefei Song, Xianqun Fan

    Published 2025-01-01
    “…It includes clinical data, T2-weighted MRI scans, and corresponding segmentations from 500 patients with thyroid eye disease (TED) during their initial visit. TED is a common autoimmune disorder with distinct orbital MRI features. …”
    Get full text
    Article
  9. 29

    A review on eye diseases induced by blue light: pathology, model, active ingredients and mechanisms by Yuan Yan, Yuan Yan, Yuan Yan, Yiyao Wu, Yiyao Wu, Yiyao Wu, Yu Zhao, Yu Zhao, Yu Zhao, Yaguang Yang, Yaguang Yang, Yaguang Yang, Guangtao An, Guangtao An, Guangtao An, Zhidong Liu, Zhidong Liu, Zhidong Liu, Zhidong Liu, Dongli Qi, Dongli Qi, Dongli Qi

    Published 2025-01-01
    “…Specific symptoms include dryness and discomfort in the eyes, blurred vision, headache, insomnia, and in severe cases, it may also cause various eye diseases such as cataracts and glaucoma. At present, the development of health products and drugs for eye blue light injury faces many difficulties. …”
    Get full text
    Article
  10. 30

    Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients by Yuri Sakane, Masahiko Yamaguchi, Atsushi Shiraishi

    Published 2019-01-01
    “…The purpose of this study was to determine the effect of rebamipide (RBM) on the QOL of Japanese patients with dry eye disease (DED). Method. The medical records of 43 patients (3 men and 40 women; mean age: 64 ± 14 years; range: 32 to 83 years), who were diagnosed with DED and treated with RBM at the Ehime University Hospital between November 2012 and June 2016, were reviewed. …”
    Get full text
    Article
  11. 31

    A Novel Three-Dimensional Vector Analysis of Axial Globe Position in Thyroid Eye Disease by Jie Guo, Jiang Qian, Yifei Yuan, Rui Zhang, Wenhu Huang

    Published 2017-01-01
    “…To define a three-dimensional (3D) vector method to describe the axial globe position in thyroid eye disease (TED). Methods. CT data from 59 patients with TED were collected and 3D images were reconstructed. …”
    Get full text
    Article
  12. 32

    The Efficacy of Clinical Tests to Diagnose Evaporative Dry Eye Disease Related to Meibomian Gland Dysfunction by Jerry R. Paugh, Tiffany Nguyen, Alan Sasai, Elaine Chen, Melinda Thomas De Jesus, Justin Kwan, Andrew Loc Nguyen, Marjan Farid, Sumit Garg, James V. Jester

    Published 2022-01-01
    “…To determine the efficacy of widely available subtype clinical tests to characterize evaporative dry eye disease (EDED) related to meibomian gland dysfunction (MGD) compared to normal and to validate those clinical cut points in an independent sample. …”
    Get full text
    Article
  13. 33
  14. 34

    The Prevalence of Age-Related Eye Diseases and Cataract Surgery among Older Adults in the City of Lodz, Poland by Michal Szymon Nowak, Janusz Smigielski

    Published 2015-01-01
    “…To determine the prevalence of age-related eye diseases and cataract surgery among older adults in the city of Lodz, in central Poland. …”
    Get full text
    Article
  15. 35
  16. 36

    Dry eye disease treatment improves subjective quality-of-life responses in patients with AMD, independent of disease stage. by Nehal Nailesh Mehta, Ines D Nagel, Akshay Agnihotri, Anna Heinke, Lingyun Cheng, Dirk-Uwe Bartsch, William R Freeman, Maria-Laura Gomez

    Published 2025-01-01
    “…<h4>Purpose</h4>To determine the impact of severity of age-related macular degeneration (AMD) on subjective treatment response in patients treated for dry eye disease.<h4>Methods</h4>A total of 203 eyes diagnosed with evaporative dry eye disease (DED) due to meibomian gland dysfunction were treated using the LipiFlow or MiBoFlo systems. …”
    Get full text
    Article
  17. 37

    Efficacy of Topical Hydrocortisone in Combination with Topical Ciclosporin A for the Treatment of Dry Eye Disease in Patients with Sjögren Syndrome by Klemens Fondi, Kata Miháltz, Pia Veronika Vécsei-Marlovits

    Published 2021-01-01
    “…The aim of this randomized, observer-masked, parallel group study was to evaluate the short-term and long-term effects of topical hydrocortisone administered in addition to topical ciclosporin A for the first 2 weeks of the treatment in patients with dry eye disease associated with Sjögren syndrome. Materials and Methods. 24 eyes of 12 patients with severe dry eye disease associated with Sjögren syndrome were included in this study. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40